We were able to demonstrate that overexpression of ADAM10 in transgenic mice [11] and acitretin-induced upregulation of ADAM10 gene expression in an AD mouse model [12] leads to a significant reduction of A-beta peptides. Here, ADAM10 is linked to Alzheimer disease.